Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Hyi-Jeong Ji"'
Autor:
Hyun-Jung Park, Hyun Soo Shim, Sunyoung Lee, Dae Hyun Hahm, Hyejung Lee, Chang Taek Oh, Hae Jung Han, Hyi Jeong Ji, Insop Shim
Publikováno v:
BMC Complementary and Alternative Medicine, Vol 18, Iss 1, Pp 1-8 (2018)
Abstract Background Human placenta hydrolysate (hPH) has been utilized to improve menopausal, fatigue, liver function. Its high concentration of bioactive substances is known to produce including antioxidant, anti-inflammatory and anti-nociceptive ac
Externí odkaz:
https://doaj.org/article/67b93f78204e47eda10fde0a044de7d1
Autor:
Jürgen Kratzsch, Mohamed El Kholy, Paul Saenger, Jin Hwa Lee, Rajesh Khadgawat, Vaman Khadilkar, Valentina Peterkova, Verónica Mericq, M Desai, Yoon Ju Bae, Elena Bolshova, Hyi-Jeong Ji, E. Christine Siepl, Prema Lopez, Klavdia A. Radjuk, Dieter Martin
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 99:126-132
Sustained-release GH formulations may provide a strategy for improving treatment compliance and persistence in GH-deficient patients.The aim of the study was to examine efficacy and safety of LB03002, a sustained-release GH formulation for once-weekl
Autor:
Yo-Kyung Chung, Chihwa Kim, Eui-cheol Jo, Jinwook Seo, Jongmun Sohn, Byoung-Ju Lee, Hyi-Jeong Ji, Jaehyeon Lee
Publikováno v:
Journal of Human Genetics
Hunter syndrome is an X-linked lysosomal storage disease caused by a deficiency in the enzyme iduronate-2-sulfatase (IDS), leading to the accumulation of glycosaminoglycans (GAGs). Two recombinant enzymes, idursulfase and idursulfase beta are current
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 97:400-407
GH treatment currently requires daily sc injections, resulting in suboptimal compliance. A GH regimen with fewer injections may offer patients and caregivers a less arduous option. LB03002 is a novel sustained-release GH formulation for once-weekly d
Autor:
Catalin Gavrila, Hyi-Jeong Ji, E. Christine Siepl, Christian J. Strasburger, Mihail Coculescu, Vera Popovic, Conrad Savoy, J. Roemmler, Beverly M. K. Biller, David M. Cook, Hyunji Ahn
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 96:1718-1726
A sustained-release recombinant human GH formulation, LB03002, has been recently developed, with pharmacokinetics and pharmacodynamic activity appropriate for once-weekly administration. LB03002 is a long-acting GH that is administered once a week by
Autor:
Paul Saenger, Valentina Alexandrovna Peterkova, Hyi-Jeong Ji, Ilknur Arslanoglu, Elena Bolshova-Zubkovskaya, Tomasz Romer, Jürgen Kratzsch, Conrad Savoy, Dragan Zdravkovic
Publikováno v:
Hormone Research in Paediatrics. 68:288-293
Valtropin is a recombinant human GH (rhGH) manufactured using a novel yeast expression system, classed as a ‘biosimilar’. Valtropin was compared with Humatrope in children with GH deficiency (GHD). Treatment-naive, prepubertal children with GHD w
Autor:
Hyi Jeong Ji, Beom Joon Kim, Eun Ja Choi, Hye Min Park, Chang Taek Oh, Hae Jung Han, Tae-Rin Kwon
Publikováno v:
International journal of molecular medicine. 36(4)
Human placental extract (HPE) is widely used in Korea to relieve fatigue. However, its effects on human dermal papilla cells (hDPCs) remain unknown. In the present study, in an effort to develop novel therapies to promote hair growth, we screened HPE
Autor:
Jong-Hwan Park, Sun-A Cho, Hyi-Jeong Ji, Youn-Sung Choo, Jae-Hyeon Juhn, Seong-Jin Kim, Jae-Hak Park, Seung Hyeok Seok
Publikováno v:
Experimental and Toxicologic Pathology. 57:321-328
The present study was performed to investigate the protective effects of granulocyte macrophage-colony stimulating factor (GM-CSF) against ulcerative mucositis in hamster buccal pouch. GM-CSF was topically administered to the buccal pouches of hamste
Autor:
Kee Hyoung Lee, Woo Yeong Chung, Jin Soon Hwang, Byung Kyu Suh, Hyunji Ahn, Duk Hee Kim, Hyi Jeong Ji, Sei Won Yang, Cheol Woo Ko, Ho-Seong Kim, Han Wook Yoo
Publikováno v:
Yonsei Medical Journal
Purpose: It has been reported that daily recombinant human growth hormone (GH) treatment showed beneficial effects on growth in prepubertal children with idiopathic short stature (ISS). The present study aimed to validate the GH (Eutropin ® ) effect
Autor:
Johannes D. Veldhuis, Valentina Alexandrovna Peterkova, Paul Saenger, Marta Barontini, Ilknur Arslanoglu, Martijn H. Breuning, María Cecilia García Rudaz, W. Oostdijk, Delphine Mitanchez, Tomasz Romer, Pierre Chatelain, Marwa E. Fahmi, Hyi-Jeong Ji, Peter J Simm, Robert L. Rosenfield, María Gabriela Ropelato, Pinchas Cohen, Conrad Savoy, Guy Van Vliet, María Gabriela Ballerini, M.H. de Ru, Mirta Gryngarten, Jürgen Kratzsch, G Bona, Mohamed El Kholy, Eileen Fowler, Samia Selim, Margaret Zacharin, Wolfgang G. Sippell, Melanie Shim, J.M. Wit, Heba Elsedfy, Elena Bolshova-Zubkovskaya, William L. Oppenheim, A. Ferrandez-Longas, Ayman E. Nassar, A. Carrascosa, Claude J. Migeon, M E Escobar, F K Grote, H.M. Zonderland, Dragan Zdravkovic, Omar Ali, S.G. Kant
Publikováno v:
Hormone Research in Paediatrics. 68:327-329